Skip to main content

Table 6 Conditioning regimens for multiple myeloma and lymphoma

From: The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

Conditioning regimen

Drug

Dose (total)

Time(d)

Transplantation type

BEAM

BCNU

300 mg/m2

−6

Allo-HSCT of lymphoma

Vp16

800 mg/m2

−5 ~ − 2

Ara-C

800 mg/kg

−5 ~ − 2

Mel

140 mg/m2

−1

Flu/MEL

Flu

150 mg/m2

−7 ~ − 3

Allo-HSCT of multiple myeloma

Mel

140 mg/m2

−2, − 1

Bortizomib

  

Flu/Bu

Flu

150 mg/m2

−10 ~ 6

Allo-HSCT of multiple myeloma

Bu

6.4~ 9.6 mg/kg (iv)

− 7 ~ − 4

  1. BCNU carmustine, VP16 etoposide, Ara-C cytarabine, Mel melphan, Flu fludarabine, Bu busulfan, allo-HSCT allogeneic hematological stem cell transplantation